Research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note issued to investors on Friday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Price Performance
NYSE:MLSS opened at $0.66 on Friday. The firm has a 50-day moving average of $0.69 and a 200-day moving average of $0.66. The company has a market cap of $50.97 million, a PE ratio of -6.60 and a beta of 0.89. Milestone Scientific has a one year low of $0.52 and a one year high of $1.35.
Milestone Scientific (NYSE:MLSS – Get Free Report) last posted its earnings results on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%. The business had revenue of $2.25 million for the quarter.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Further Reading
- Five stocks we like better than Milestone Scientific
- Overbought Stocks Explained: Should You Trade Them?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Investing In Automotive Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
